A mutational signature in gastric cancer suggests therapeutic strategies.
Siu, Hoi Cheong
Leung, Suet Yi
Stratton, Michael R
Springer Science and Business Media LLC
MetadataShow full item record
Alexandrov, L. B., Nik-Zainal, S., Siu, H. C., Leung, S. Y., & Stratton, M. R. (2015). A mutational signature in gastric cancer suggests therapeutic strategies.. Nat Commun, 6 8683. https://doi.org/10.1038/ncomms9683
Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure of double-strand DNA break repair by homologous recombination based on its high mutational burden in samples harbouring BRCA1 or BRCA2 mutations. In pancreatic cancer, all responders to platinum therapy exhibit this mutational signature including a sample that lacked any defects in BRCA1 or BRCA2. Here, we examine 10,250 cancer genomes across 36 types of cancer and demonstrate that, in addition to breast, ovarian and pancreatic cancers, gastric cancer is another cancer type that exhibits this mutational signature. Our results suggest that 7-12% of gastric cancers have defective double-strand DNA break repair by homologous recombination and may benefit from either platinum therapy or PARP inhibitors.
BRCA1 Protein, BRCA2 Protein, Breast Neoplasms, DNA Breaks, DNA Repair, Female, Humans, Male, Mutation, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms
External DOI: https://doi.org/10.1038/ncomms9683
This record's URL: https://www.repository.cam.ac.uk/handle/1810/284499
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org